Flecainide toxicity-Clinical diagnosis and management of an urgent condition.

bizarre ECG, wide QRS tachycardia drug toxicity flecainide toxicity

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 14 06 2024
revised: 28 06 2024
accepted: 13 07 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

Clinical suspicion, clinical presentation, and electrocardiogram can help clinicians diagnose flecainide toxicity. Currently, there are no guidelines for the management of patients with flecainide toxicity. Sodium bicarbonate, lipid emulsion therapy, and extracorporeal life support have been used in this setting. Amiodarone and lidocaine can be used for the management of wide QRS complex tachycardias in hemodynamically stable patients with flecainide toxicity.

Identifiants

pubmed: 39219784
doi: 10.1002/ccr3.9371
pii: CCR39371
pmc: PMC11362020
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e9371

Informations de copyright

© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

George Bazoukis (G)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.
European University Cyprus Medical School Nicosia Cyprus.

Polyxeni Efthymiou (P)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Andronicos Yiannikourides (A)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Elina Khattab (E)

Department of Cardiology Nicosia General Hospital Nicosia Cyprus.

Varnavas Dimitriades (V)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Gary Tse (G)

Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University Tianjin China.
School of Nursing and Health Studies Hong Kong Metropolitan University Hong Kong China.

Marios Pavlou (M)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Panagiota Georgiou (P)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Lorentzos Kapetis (L)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Dimitrios Patestos (D)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Michalis Tsielepis (M)

Department of Cardiology Larnaca General Hospital Larnaca Cyprus.

Kimon Myrianthopoulos (K)

Department of Cardiology Nicosia General Hospital Nicosia Cyprus.

Elias Papasavvas (E)

Electrophysiology Laboratory Aretaeio Hospital Nicosia Cyprus.

Theodoros Christophides (T)

Department of Cardiology Nicosia General Hospital Nicosia Cyprus.

Classifications MeSH